STAT

STAT+: In autopsy of failed heart disease study, AstraZeneca raises broader questions about silencer drugs

STAT+: In autopsy of failed heart disease study, AstraZeneca raises broader questions about silencer drugsWorldPing

AstraZeneca detailed the surprise failure of a closely watched heart disease trial, a study with ripple effects for a competitive billion-dollar market.

This is a short WorldPing brief. The full report was published by STAT.

Read the full report at STAT

Related news

French ruling spotlights breast cancer as an occupational diseaseWorldPing
The Hindu

French ruling spotlights breast cancer as an occupational disease

A flight attendant’s legal battle highlights the health risks of night shifts and exposure to cosmic radiation, after a French court recognises breast cancer as an occupational disease…

Brief by WorldPing · Original reporting by The Hindu